-
Liver Cancer Drugs Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034)
18 Jun 2025 11:30 GMT
… rates, growing healthcare expenditure globally, increasing … increasing precision medicine adoption, rising drug approvals worldwide … Pharmaceutical Company Limited, Hetero Drugs Limited, Sun pharma, Eisai Company Limited, Genentech Incorporated, Ipsen …
-
Podcast curriculum improves fellows’ comfort with, knowledge of medical topics
12 Jun 2025 00:20 GMT
… hematology oncology at Vanderbilt University Medical Center, said during a presentation … follows Accreditation Council for Graduate Medical Education guidelines and American Board … roles with Acrotech Biopharma and Ipsen, honoraria from Curio Science, and …
-
Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline | DelveInsight
20 Jun 2025 00:25 GMT
… neuroendocrine tumors. Advancements in antibody-drug conjugate (ADC) technology and … Jiangsu HengRui Medicine, Aileron Therapeutics, Roche, Ipsen, Celgene, Lee’s Pharmaceutical Limited, … access to all the healthcare and pharma market research reports through …
-
Pediatric Glioma Drugs Market to Surpass USD 11 Billion by 2034, with an 8% CAGR | Exactitude Consultancy
05 Jun 2025 14:08 GMT
… from growing healthcare awareness and improving access to medical services. … Group)
AstraZeneca
Teva Pharmaceutical Industries
Ipsen
Recent Market Developments
… hyperinsulinism-hi-drugs-market Fermentation Engineering for Pharmaceutical Drugs Market The …
-
The Medical Affairs Professional Society announces Robin Winter-Sperry, MD, as new President for the Americas Region.
03 Jun 2025 14:30 GMT
… a future where medical advancements lead to meaningful health outcomes, and I … Head of Global Field-Based Medical at Ipsen. At Sanofi Genzyme, she … advance the Medical Affairs field. MAPS connects professionals from pharmaceuticals, biotech, MedTech …
-
Leading Driver In The Prostate Cancer Therapeutics Market 2025: Surge In Aging Population And Increased Life Expectancy
19 Jun 2025 11:33 GMT
… spending in healthcare, burgeoning investments in oncology drugs, greater … Medicine Co. Ltd., Telix Pharmaceuticals, Bayer AG, Curium Pharma SAS, Dendreon Pharmaceuticals … , Myovant Sciences GmbH, Clovis Oncology Inc., Ipsen …
-
Ipsen’s Cabometyx kidney cancer reimbursement bid collapses in Korea after price talks fail
30 May 2025 09:06 GMT
… -line immuno-oncology combinations,” an Ipsen Korea spokesperson told Korea Biomedical … Committee and Drug Reimbursement Evaluation Committee (DREC) under the Health Insurance Review …
-
Tolmar Pharmaceuticals Canada, Inc. appoints new General Manager
29 May 2025 04:20 GMT
… the CEO at Ipsen North America. MISSISSAUGA — Tolmar Pharmaceuticals Canada, Inc. announces … to therapies through collaboration with healthcare professionals and payors.
“I’m … our teams and the broader healthcare community to advance patient care …
-
Glasgow student will go blind 'imminently' if she doesn't receive treatment drug from US
26 May 2025 09:37 GMT
… medication will cost her £26,000 a month to receive. The drug … taken over by a new pharmaceutical company IPSEN. Beau wasn't … eligible for the trial of the drug … and Health Secretary Neil Gray in a push for the drug to …
-
Student in race to save eyesight as family make fundraising plea for new drug from US
22 May 2025 05:50 GMT
… builds up tolerance to different medications, and I get really … hoped a “promising” new drug in the United States, … and tried to get it.”
Health secretary Neil Gray said: … the pharmaceutical company, Ipsen, are meeting with the Chief Pharmaceutical Officer …
About
© 1995-2025